SPE-MS analysis of absorption, distribution, metabolism and excretion assays: A tool to increase throughput and steamline workflow

Bioanalysis

Volumn 4, Issue 9, 2012, Pages 1111-1121

  Miller, Vaughn P ^a  

^a Agilent Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; DIGOXIN; KETOPROFEN; TOLTERODINE; VALSARTAN;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SOLUBILITY; ENZYME INHIBITION; HUMAN; IC 50; IN VIVO STUDY; INFORMATION PROCESSING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; ONLINE SYSTEM; PERMEABILITY; QUANTITATIVE ANALYSIS; REVIEW; SOLID PHASE EXTRACTION;

ABSORPTION; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SOLID PHASE EXTRACTION;

EID: 84861351776     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.86     Document Type: Review

References (59)

1. Hop CE, Cole MJ, Davidison RE et al. High throughput ADME screening: Practical considerations, impact on the portfolio and enabler of in silico ADME models. Curr. Drug Metab. 9(9), 847-853 (2008).
2. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3, 711-716 (2004).
3. Aubry A-F. LC-MS/MS bioanalytical challenge: Ultra-high sensitivity assays. Bioanalysis 3(16), 1819-1825 (2011).
4. Shou WZ, Zhang J. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling. Expert Opin. Drug Metab. Toxicol. 6(3), 321-226 (2010).
5. Bakhiar R, Ramos L, Tse FLS. High-throughput mass spectrometric analysis of xenobiotics in biological fluids. J. Liq. Chrom. Rel. Technol. 25(4), 507-540 (2002).
6. Van den Ouweland JMW, Kema IP. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory. J. Chromatogr. B 883-884, 18-32 (2012).
7. O'Connor D, Mortishire-Smith R. High-throughput bioanalysis with simultaneous acquisition of metabolic route data using ultra performance liquid chromatography coupled with time-of-flight mass spectrometry. Anal. Bioanal. Chem. 385, 114-121 (2006).
8. Parikh N, Romm MV, Dai Y, Miller VP, LaMarr WA. Ultra-fast SPE integrated with TOF-MS increases the throughput of metabolic stability assays and enables analysis of metabolites. Presented at: The 59th ASMS Conference on Mass Spectrometry and Allied Topics. Denver, CO, USA, 5-9 June 2011.
9. Henion J, Brewer E, Rule G. Sample preparation for LC-MS/MS: Analyzing biological and environmental samples Anal. Chem. 70(19), 650A-656A (1998).
10. Briem S, Pettersson B, Skoglund E. Description and validation of a four-channel staggered LC-MS/MS system for high-throughput in vitro screens. Anal. Chem. 77(6), 1905-1910 (2005).
11. Yu S, Crawford E, Tice J, Musselman B, Wu JT. Bioanalysis without sample cleanup or chromatography: The evaluation and initial implementation of direct analysis in real time ionization mass spectrometry for the quantification of drugs in biological matrixes. Anal. Chem. 81, 193-202 (2009).
12. Wu J, Hughes CS, Picard P et al. High-throughput cytochrome P450 inhibition assays using laser diode thermal desorption-atmospheric pressure chemical ionization- tandem mass spectrometry. Anal. Chem. 79(12), 4657-4665 (2007).
13. Bjornsson TD, Callaghan JT, Einolf HJ et al. The conduct of in vitro and in vivo drug-drug interaction studies: A pharmaceutical research and manufacturers of America (PhRMA) perspective. Drug Metab. Dispos. 31(7), 815-832 (2003).
14. Bu H-Z, Magis L, Knuth K, Teitelbaum P. High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/online guard cartridge extraction/ tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolites. Rapid Comm. Mass Spectrom. 14, 1619-1624 (2000).
15. Quercia AK, LaMarr WA, Myung J, Ozbal CC, Landro JA, Lumb KJ. High-throughput screening by mass spectrometry: Comparison with the scintillation proximity assay with a focused-file screen of AKT1/PKBa. J. Biomol. Screen 12, 473-480 (2007
16. Forbes CD, Toth JG, Ozbal CC et al. High-throughput mass spectrometry screening for inhibitors of phsphatidylserine decarboxylase. J. Biomol. Screening 12, 628-634 (2007).
17. Rye PT, Frick LE, Ozbal CC, Lamarr WA. Advances in label-free screening approaches for studying histone acetyltransferases. J. Biomol. Screening 16(10), 1186-1195 (2011).
18. Rye PT, Frick LE, Ozbal CC, Lamarr WA. Advances in label-free screening approaches for studying sirtuin-mediated deacetylation. J. Biomol. Screening 16(10), 1217-1226 (2011).
19. Shiau AK, Massari ME, Ozbal CC. Back to basics: Label-free technologies for small molecule screening. Comb. Chem. High Throughput Screen. 11, 231-237 (2008).
20. Brown A, Bickford S, Hatsis P, Amin J, Bell L, Harriman S. High-throughput analysis of in vitro cytochrome P450 inhibition samples using mass spectrometry coupled with an integrated liquid chromatography/autosampler system. Rapid Commun. Mass Spectrom. 24(8), 1207-1210 (2010).
21. Perloff E, Dehal SS, Mason AK et al. Comparison of RapidFire ultra high throughput LC-MS/MS with traditional LC-MS/MS for cytochrome P450 inhibition testing. Presented at: The 11th European ISSX Meeting. Lisbon, Portugal, 17-20 May 2009.
22. Miller VP, Ozbal CC, Perloff ES et al. Evaluation of high throughput screening methods for time-dependent inhibition of CYP3A4 utilizing RapidFire LC-MS/MS technology. Presented at: The 11th European ISSX Meeting. Lisbon, Portugal, 17-20 May 2009.
23. Lim KB, Ozbal CC, Kassel DB. Development of a high-throughput online solid-phase extraction-tandem mass spectrometry method for cytochrome P450 inhibition screening. J. Biomol. Screening 15(4), 447-452 (2010).
24. Luippold AH, Arnold T, Jorg W, Kruger B, Sussmuth RD. Application of a rapid and integrated analysis system (RIAS) as a high-throughput processing tool for in vitro ADME samples by liquid chromatography- tandem mass spectrometry. J. Biomol. Screening 16(3) 370-377 (2011).
25. Kerns EH, Kleintop T, Little D et al. Integrated high capacity solid phase extraction-MS/MS system for pharmaceutical profiling in drug discovery. J. Pharm Biomed. Anal. 34(1), 1-9 (2004).
26. Janiszewski JS, Rogers KJ, Whalen KM et al. A High-capacity LC-MS system for the bioanalysis of samples generated from plate-based metabolic screening. Anal. Chem. 73, 1495-1501 (2001).
27. Yan Z, Lu C, Wu JT, Elvebak L, Brockman A. Validation of a high-throughput absorption, distribution, metabolism, and excretion (ADME) system and results for 60 literature compounds. Rapid Commun. Mass Spectrom. 19, 1191-1199 (2005).
28. Zheng JJ, Lynch ED, Unger SE. Comparison of SPE and fast LC to eliminate mass spectrometric matrix effects from microsomal incubation products. J. Pharm. Biomed. Anal. 28(2), 279-285 (2002).
29. Inman BL, Chovan LE, Dandliker PJ, Yau YL. Solid phase extraction as a faster alternative to HPLC: Application to MA analysis of metabolic stability samples. J. Pharm. Sci. 96(6), 1619-1624 (2007).
30. Luippold AH, Arnold T, Jorg W, Sussmuth RD. An integrated platform for fully automated high-throughput LC-MS/MS analysis of in vitro metabolic stability assay samples. Internat. J. Mass Spectrom. 296, 1-9 (2010).
31. Hatsis P, Romm M, Miller V et al. Reducing bottlenecks in ADME sample analysis using solid phase extraction with a quadrupole time-of-flight mass spectrometer. Presented at: The 58th American Society for Mass Spectrometry Conference Mass Spectrometry and Allied Topics. Salt Lake City, UT, USA, 23-27 May 2010.
32. Bu H-Z, Poglod M, Micetich RG, Khan JK. High-throughput Caco-2 cell permeability screening by cassette dosing and sample pooling approaches using direct injection/ online guard cartridge extraction/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 14, 523-528 (2000).
33. Amaral AC, Caldwell C, Hatsis P, Amin J, Harriman S. Comparison of LC-MS/MS and a fully integrated autosampler/solid phase extraction system for the analysis of permeability samples. Presented at: The 58th American Society for Mass Spectrometry Conference Mass Spectrometry and Allied Topics. Salt Lake City, UT, USA, 23-27 May 2010.
34. Wagner AD, Kolb JM, Ozbal CC et al. Ultrafast mass spectrometry based bioanalytical method for digoxin supporting an in vitro P-glycoprotein (P-gp) inhibition screen. Rapid Commun. Mass Spectrom. 25, 1231-1240 (2011).
35. Hatsis P, Romm MV, Miller VP, Lamarr WA, Amin J, Harriman S. Ultra-fast solubility sample analysis using SPE-TOF. Presented at: The American Association of Pharmaceutical Sciences Annual Meeting and Exposition. New Orleans, LA, USA, 14-18 November 2010.
36. Jemal M. Ouyang Z, Xia Y-Q. Systematic LC-MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed. Chromatogr. 24, 2-19 (2010).
37. Bowers GD, Clegg CP, Hughes SC, Harker AJ, Lambert S. Automated SPE and tandem MS without HPLC columns for quantifying drugs at the pictogram level. LC-GC 15(1), 48-53 (1997).
38. Van Hout MWJ, Hofland CM, Niederlander HAG, Bruins AP, De Zeeuw RA, De Jong GJ. Online coupling of solid-phase extraction with mass spectrometry for the analysis of biological samples III. Determination of prednisolone in serum. J. Chromatogr. B 794, 185-192 (2003).
39. Calderon-Santiago M, Mata-Granados JM, Preigo-Capote F, Quesada-Gomez JM, Luque De Castro MD. Analytical platform for verification and quantitation of target peptides in human serum: Application to cathelicidin. Anal. Biochem. 415, 39-45 (2011).
40. Schellen A, Ooms B, Van Gils M et al. High throughput online solid phase extraction/ tandem mass spectrometry determination of paclitaxel in human serum. Rapid Commun. Mass Spectrom. 14, 230-233 (2000).
41. Swart R, Koivisto P, Markides KE. Capillary solid-phase extraction-tandem mass spectrometry for fast quantification of free concentrations of tolterodine and two metabolites in ultrafiltered plasma samples. J. Chromatogr. B 736, 247-253 (1999).
42. Pickl KE, Magnes C, Bodenlenz M, Pieber TR, Sinner FM. Rapid online-SPE-MS/MS method for ketprofen determination in dermal interstitital fluid samples from rats obtained by micodialysis or open-flow microperfusion. J. Chromatogr. B 850, 432-439 (2007).
43. Levi M, Wuerzner G, Ezan E, Pruvost A. Direct analysis of valsartan or candesartan in human plasma and urines by online solid phase extraction coupled to electrospray tandem mass spectrometry. J. Chromatogr. B 877, 919-926 (2009).
44. Jian W, Romm MV, Edom RW, Miller VP, LaMarr WA, Weng N. Evaluation of a high-throughput online solid phase extraction-tandem mass spectrometry system for in vivo bioanalytical studies. Anal. Chem. 83, 8259-8266 (2011
45. Romm MV, Korman EW, Miller VP et al. High-throughput analysis of levetiracetam in serum using ultrafast SPE-MS/MS. Presented at: The 59th American Society for Mass Spectrometry Conference Mass Spectrometry and Allied Topics. Denver, CO, USA, 5-9 June 2011.
46. Schlicht K, Korman EW, Miller VP et al. High-throughput analysis of tacrolimus in whole blood using ultrafast SPE-MS/MS. Presented at: The 59th American Society for Mass Spectrometry Conference Mass Spectrometry and Allied Topics. Denver, CO, USA, 5-9 June 2011.
47. Himmelsbach M. 10 years of MS instrumental developments - impact on LC-MS/MS in clinical chemistry. J. Chromatogr. B 883-884, 3-17 (2012).
48. Hatsis P, Kapron JT. A review on the application of high-field asymmetric waveform ion mobility spectrometry (FAIMS) in drug discovery. Rapid Commun. Mass Spectrom. 22, 735-738 (2008).
49. Kanu AB, Dwivedi P, Tam M, Matz L, Hill HH. Ion mobility-mass spectrometry. J. Mass Spectrom. 43, 1-22 (2008).
50. Ding J, Neue UD. A new approach to the effective preparation of plasma samples for rapid drug quantitation using on-line solid phase extraction mass spectrometry. Rapid Commun. Mass Spectrom. 13, 2151-2159 (1999).
51. Mallet CR, Mazzeo JR, Neue U. Evaluation of several solid phase extraction liquid chromatography/tandem mass spectrometry on-line configurations for high-throughput analysis of acidic and basic drugs in rat plasma. Rapid Commun. Mass Spectrom. 15, 1075-1083 (2001).
52. Bruins CHP, Jeronimus-Stratingh CM, Ensing K, Van Dongen WD, De Jong GJ. On-line coupling of solid-phase extraction with mass spectrometry for the analysis of biological samples I. determination of clenbuterol in urine. J. Chromatogr. A 863, 115-122 (1999).
53. Schmidt A, Karas M, Dulcks TJ. Effect of different solution flow rates on analyte ion signals in nano-ESI MS, or: When does ESI turn into nano-ESI? J. Am. Soc. Mass Spectrom. 14, 492-500 (2003).
54. Michopoulos F, Edge AM, Hui Y-T, Liddicoat T, Theodoridis G, Wilson ID. Extraction methods for the removal of phospholipids and other endogenous material from a biological fluid. Bioanalysis 3(24), 2747-2755 (2011).
55. Haginaka J. Molecularly imprinted polymers as affinity-based separation media for sample preparation. J. Sep. Sci. 32(10), 1548-1565 (2009).
56. Van Hout MWJ, Niederlander HAG, De Zeeuw RA, De Jong GJ. Ion suppression in the determination of clenbuterol in urine by solid-phase extraction atmospheric pressure chemical ionization ion-trap mass spectrometry. Rapid Commun. Mass Spectrom. 17, 245-250 (2003).
57. Yuan C, Kosewich J, Xiang H, Kozak M, Wang S. Sensitive measurement of serum 1alpha,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun. Mass Spectrom. 25, 1241-1249 (2011).
58. Youdim KA, Saunders KC. A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s. J. Chromatogr. B 878, 1326-1336 (2010).
59. Bateman KP, Kellmann M, Muenster H, Papp R, Taylor L. Quantitative-qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20(8), 1441-1450 (2009